|
Antonio Gotto: Pathfinder in Primary Care
|
|
|
| By
William Looney
|
|
|
|
Antonio Gotto, MD, Dean, Weill Cornell Medical College
|
|
|
|
Fernand Sauer: The Essential—and Effective—Bureaucrat
|
|
|
|
Fernand Sauer, First Director General, European Medicines Agency
|
|
|
|
Sir Michael Rawlins: Regulation and Reputation
|
|
|
|
Sir Michael Rawlins, Chairman of the UK National Institute for Health and Clinical Excellence
|
|
|
|
Partnering with the New Players
|
|
|
| By
William Looney
|
|
|
|
Carlos Morel, MD, Director for Technical Development in Health, Oswaldo Cruz Foundation
|
|
|
|
Martin Wygod: Arming up for the Digital Revolution
|
|
|
|
Martin Wygod, Chairman, WebMD
|
|
|
|
Francis Collins: Guiding a Revolution in Science
|
|
|
| By
Jill Wechsler
|
|
|
|
Francis Collins, MD, PhD, Director, National Institutes of Health
|
|
|
|
Fred Frank: Fortune and the Financier
|
|
|
|
Fred Frank, Vice Chairman, P.J. Solomon Co.
|
|
|
|
Janet Woodcock: At the Helm of Industry
|
|
|
| By
Jill Wechsler
|
|
|
|
Janet Woodcock, MD, Director, FDA Center for Drug Evaluation and Research
|
|
|
|
IP: Securing a Global Consensus—Can Industry Do It Again?
|
|
|
| By
Ansis Helmanis
|
|
|
|
Harvey Bale, Jr., MD, former Director-General, IFPMA
|
|
|
|
Sir Martin Sorrell: Teamwork and Trust
|
|
|
| By
William Looney
|
|
|
|
Sir Martin Sorrell, CEO, WPP
|
|
|
|
Abbey Meyers: The "Mother" of Invention
|
|
|
| By
Jennifer Ringler
|
|
|
|
Abbey Meyers, Founder, National Organization of Rare Disorders
|
|
|
|
Physicians: Still the Vital Connection in Medicine
|
|
|
|
Jean-Claude Labrune, Chairman & CEO, Cegedim Group
|
|
|
|
Y. K Hamied : Changing the Dialogue
|
|
|
|
Y.K. Hamied, PhD, Chairman, Cipla
|
|
|
|
Sidney Wolfe: Pharma's Unlikely Best Friend
|
|
|
| By
Jill Wechsler
|
|
|
|
Sidney Wolfe, MD, Director, Public Citizen's Health Research Group
|
|
|
|
Angus Russell: Bravura Performer
|
|
|
| By
William Looney
|
|
|
|
Angus Russell, CEO, Shire
|
|
|
|
In Establishing the Evidence Base, He Made Science Count
|
|
|
| By
David Balekdjian
|
|
|
|
Robert Seidman, Former Chief Pharmacy Officer, Wellpoint
|
|
|
|
Candan Carabagli: The East is Up
|
|
|
| By
William Looney
|
|
|
|
Candan Karabagli, CEO, Abdi Ibrahim A.S.
|
|
|
|
Josef von Rickenbach: The Enterprising CRO
|
|
|
| By
Ben Comer
|
|
|
|
Josef von Rickenbach, President & CEO, Parexel
|
|
|
|
Productivity, Reputation are Keys to Global Leadership
|
|
|
| By
William Looney
|
|
|
|
Yasuchika Hasegawa, President & CEO, Takeda Pharmaceutical Co.
|
|
|
|
Henry Grabowski: Academia Sweet Spot
|
|
|
|
Henry Grabowski, PhD, Professor of Economics, Duke University
|
|
|
|
Henry Waxman: "Representing" Healthcare to the Fullest
|
|
|
| By
Jill Wechsler
|
|
|
|
Henry Waxman, Congressional Representative from Los Angeles, California
|
|
|
|
Marck McLellan: An 'A' for Advancing Expectations
|
|
|
| By
Jill Wechsler
|
|
|
|
Marck McClellan, MD, Director, Engelberg Center for Health Reform, Brookings Institute
|
|
|
|
Peter Piot: The Crisis Manager
|
|
|
| By
William Looney
|
|
|
|
Peter Piot, MD, Director, London School of Hygiene and Tropical Medicine
|
|
|
|
Andrew Witty: The Legacy of High Expectations
|
|
|
|
Andrew Witty, Chairman & CEO, GlaxoSmithKline
|
|
|
|
Atsushi Nagahisa: Creating Customer Value
|
|
|
|
Atsushi Nagahisa, President & CEO, RaQualia
|
|
|
|
Napoleone Ferrara: Curative Powers of Collaboration
|
|
|
| By
William Looney
|
|
|
|
Napoleone Ferrara, MD, PhD, Research Fellow, Genentech
|
|
|
|
P. Roy Vagelos: Getting to No. 1—and Staying There
|
|
|
| By
William Looney
|
|
|
|
P. Roy Vagelos, MD, Chairman Emeritus, Merck
|
|
|
|
Dennis Gillings: Minting the Database
|
|
|
| By
William Looney
|
|
|
|
Dennis Gillings, Chairman & CEO, Quintils Transnational Corp.
|
|
|
|
Jane Henney: Lessons from the FDA Front Line
|
|
|
| By
Ansis Helmanis
|
|
|
|
Jane Henney, MD, Former FDA Commissioner
|
|
|
|
Sweden: Setting the Pace for Global Pharma
|
|
|
| By
Julian Upton
|
|
|
|
Garbo gets it ...
|
|
|
|
Daniel Vasella: Heart of Success
|
|
|
| By
Daniel Vasella, MD
|
|
|
|
Daniel Vasella, MD, Chairman, Novartis
|
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
